Legacy Capital Wealth Partners’s Exact Sciences EXAS Stock Holding History

Legacy Capital Wealth Partners’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-41,837	Closed	-$41.8K	–	401
2025 Q4	$41.8K	Buy	+41,837	New	+$3.36M	0.01%	375

Other funds holding EXAS

VanEck Associates

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Legacy Capital Wealth Partners's EXAS Position: Q1 2026 in Review

Legacy Capital Wealth Partners sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 41,837 shares — an estimated $41.8K sold.

Legacy Capital Wealth Partners first reported a position in EXAS in Q4 2025 and held it in 1 quarter. The position peaked at $41.8K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Legacy Capital Wealth Partners reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Legacy Capital Wealth Partners sold 41,837 Exact Sciences shares in Q1 2026, an estimated $41.8K.
Legacy Capital Wealth Partners first reported a position in Exact Sciences in Q4 2025 and held it in 1 quarter.
Legacy Capital Wealth Partners's Exact Sciences position peaked at $41.8K in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Legacy Capital Wealth Partners's 13F filing for Q1 2026, filed 15 May 2026.